nDatalyze Corp. Announces Cancellation of the Reverse Takeover of ThriveTech Holdings.
![]() | |||||||||
![]() | ![]() | ![]() | ![]() |
Calgary, Alberta – TheNewswire - April 21, 2025 - For Immediate Release – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTCQB:NDATF) has received a cancellation notice of the previously-announced reverse takeover (“RTO”) of ThriveTech Holdings, Inc. (“TTH”). TTH President, Evan Rucculo, wrote: “While we’ve identified a mechanism that works on a structural level, we've also been exploring the cross-border nature of the transaction between the U.S. and Canada from a tax perspective. Unfortunately, we've encountered some issues in this regard that we've been actively trying to resolve. Despite seeking tax advice, we have not been able to overcome these challenges and, as a result, we’re unfortunately not in a position to move forward.” The cancellation means there will be no related spin-out of the mental health-related assets and the Corporation will continue on a “business as usual” basis.
During the past few months, the Corporation has been working in the background to reconfigure its product offerings. Configurations now cover multiple verticals including electronic medical records (“EMR”) platforms, concierge/membership health services and high-performance individual performance assessments. A custom DNA panel has been specified, and testing is currently underway and expected to complete around the middle of May, 2025. The overall platform has been renamed “Sigmund” and can be seen at https://sigmundml.com.
NDAT’s President, James Durward, states: “Sigmund represents a state-of-the-art mental assessment combining extensive life experiences, genetic predispositions and expert-guided machine-learning to generate highly personalized emotional state performance assessments. These assessments fit well with the growing adoption of physical “whole-body” assessments that often lack a robust mental component. I believe that highly personalized, holistic mental/physical assessments are the future of general healthcare.”
The Corporation has approximately $500,000 cash, a burn rate of approximately $15,000 per month, and no debt.
For Further Information, please contact:
Jim Durward, President, CEO/CTO
Email: jimd@ndatalyze.com
nDatalyze Website: https://www.ndatalyze.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.